comprehensive -WSS

comprehensive

author：entertainment 2025-09-29 21:26:36 - browse：451

a liver made up by geometric shapes – biotech coverage from STAT — Adobe

Intercept Pharmaceuticals, a firm whose treatment for a prevalent liver disease once made it the hottest stock in biotech, said Tuesday it would sell the company for less than $1 billion.

Alfasigma, an Italian pharmaceutical firm, will pay $19 a share for Intercept, in a roughly $800 million cash deal that represents an 80% premium to the company’s recent trading price. Intercept expects the deal to close by the end of the year.

The transaction comes three months after the Food and Drug Administration rejected Intercept’s treatment for NASH, an increasingly common fatty liver disease perceived as a potential gold mine by drug companies. Intercept’s medicine, called obeticholic acid, would have been the first approved treatment for NASH, but serious concerns about the risk of drug-related liver damage and uncertainty over whether its modest effects would improve patients’ lives made it unapprovable in the eyes of the FDA.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： How Long Island became the ‘eugenics capital of the world’

hotspot

WSS

Neuroscience startup Neumora files for IPO

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

As pharma fights Medicare drug negotiation, hospitals, docs silent

Medicare Advantage overpayments discussion gets experts fired up

Apellis safety probe of eye disease drug centers on injection needle

Departing Stanford president retracts two papers

focus

comprehensive

Wikipedia

Apple is now the first public company to be valued at $3 trillion

Drug firms test therapies to halt Alzheimer’s before symptoms arise

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Male doctors called my cancer incurable. A female doctor showed it wasn't

Bright Health sells Medicare Advantage business to Molina

How Long Island became the ‘eugenics capital of the world’

The high cost of giving birth even with insurance

Merck to acquire Harpoon Therapeutics for $680 million

Wildfire smoke exposes gaps in outdoor worker protections

Nonprofit, backed by Microsoft, to certify AI tools in health care

focus

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Nonprofit, backed by Microsoft, to certify AI tools in health care

Does Paxlovid work in people vaccinated against Covid

How to make AI work for medicine

Study suggests new cause of Down syndrome: cells linked to aging

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

hotspot

Wikipedia

hotspot

explore